These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 26093722)

  • 1. Outcomes of Renal Transplantation in Patients With Alport Syndrome.
    Yilmaz VT; Dinckan A; Yilmaz F; Suleymanlar G; Kocak H
    Transplant Proc; 2015 Jun; 47(5):1377-81. PubMed ID: 26093722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of kidney transplantation in Alport syndrome compared with other forms of renal disease.
    Kelly YP; Patil A; Wallis L; Murray S; Kant S; Kaballo MA; Casserly L; Doyle B; Dorman A; O'Kelly P; Conlon PJ
    Ren Fail; 2017 Nov; 39(1):290-293. PubMed ID: 27917694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.
    Mallett A; Tang W; Clayton PA; Stevenson S; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Johnson DW
    Nephrol Dial Transplant; 2014 Dec; 29(12):2277-86. PubMed ID: 25061124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors and outcome in BK virus nephropathy in a Hispanic kidney transplant population.
    Pérez-Torres D; Bertrán-Pasarell J; Santiago-Delpín E; González-Ramos M; Medina-Mangual S; Morales-Otero L; González-Caraballo Z
    Transpl Infect Dis; 2010 Feb; 12(1):16-22. PubMed ID: 19804584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of renal transplantation in Alport's syndrome: a single-center experience.
    Gumber MR; Kute VB; Goplani KR; Vanikar AV; Shah PR; Patel HV; Trivedi HL
    Transplant Proc; 2012 Jan; 44(1):261-3. PubMed ID: 22310627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal transplantation in human immunodeficiency virus-infected recipients: a case-control study from the Brazilian experience.
    Vicari AR; Spuldaro F; Sandes-Freitas TV; Cristelli MP; Requião-Moura LR; Reusing JO; Pierrotti LC; Oliveira ML; Girão CM; Gadonski G; Kroth LV; Deboni LM; Ferreira GF; Tedesco-Silva H; Esmeraldo R; David-Neto E; Saitovitch D; Keitel E; Garcia VD; Pacheco-Silva A; Medina-Pestana JO; Manfro RC
    Transpl Infect Dis; 2016 Oct; 18(5):730-740. PubMed ID: 27503081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of male patients with Alport syndrome undergoing renal replacement therapy.
    Temme J; Kramer A; Jager KJ; Lange K; Peters F; Müller GA; Kramar R; Heaf JG; Finne P; Palsson R; Reisæter AV; Hoitsma AJ; Metcalfe W; Postorino M; Zurriaga O; Santos JP; Ravani P; Jarraya F; Verrina E; Dekker FW; Gross O
    Clin J Am Soc Nephrol; 2012 Dec; 7(12):1969-76. PubMed ID: 22997344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rejection after simultaneous pancreas-kidney transplantation.
    Arbogast H; Malaise J; Illner WD; Tarabichi A; Dieterle C; Landgraf R; Land W;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of alemtuzumab vs. antithymocyte globulin induction therapy in primary non-sensitized renal transplant patients treated with rapid steroid withdrawal.
    Saull HE; Enderby CY; Gonwa TA; Wadei HM
    Clin Transplant; 2015 Jul; 29(7):573-80. PubMed ID: 25711849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival in Japanese renal transplant recipients with Alport syndrome: a retrospective study.
    Katsuma A; Nakada Y; Yamamoto I; Horita S; Furusawa M; Unagami K; Katsumata H; Okumi M; Ishida H; Yokoo T; Tanabe K;
    BMC Nephrol; 2018 Oct; 19(1):249. PubMed ID: 30285655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney transplantation in patients with alport syndrome.
    Mojahedi MJ; Hekmat R; Ahmadnia H
    Urol J; 2007; 4(4):234-7. PubMed ID: 18270949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal transplantation in lupus nephritis: a Brazilian cohort.
    Oliveira CS; d Oliveira I; Bacchiega AB; Klumb EM; Albuquerque EM; Souza E; Suassuna JH; Ribeiro FM
    Lupus; 2012 Apr; 21(5):570-4. PubMed ID: 22129601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial.
    Favi E; Spagnoletti G; Salerno MP; Pedroso JA; Romagnoli J; Citterio F
    Clin Transplant; 2013; 27(4):E359-67. PubMed ID: 23710603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of renal grafts in patients with lupus nephritis as cause of end-stage renal disease.
    Villaverde Verdejo P; Fernández Rivera C; Alonso Hernández A; Garcia Naveiro R; Cao Vilariño M; Tresancos Fernández C; Valdés Cañedo F
    Transplant Proc; 2005 Apr; 37(3):1426-7. PubMed ID: 15866625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small kidneys for large recipients: does size matter in renal transplantation?
    Dinis P; Nunes P; Marconi L; Furriel F; Parada B; Moreira P; Figueiredo A; Bastos C; Roseiro A; Dias V; Rolo F; Alves R; Mota A
    Transplant Proc; 2015 May; 47(4):920-5. PubMed ID: 26036486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal transplantation from living donor parents in two brothers with Alport syndrome. Can asymptomatic female carriers of the Alport gene be accepted as kidney donors?
    Sessa A; Pietrucci A; Carozzi S; Torri Tarelli L; Tazzari S; Giordano F; Meroni M; Battini G; Valente U; Renieri A
    Nephron; 1995; 70(1):106-9. PubMed ID: 7617088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of renal transplant patients: data from a tertiary care center in Turkey.
    Soylu H; Oruc M; Demirkol OK; Saygili ES; Ataman R; Altiparmak MR; Pekmezci S; Seyahi N
    Transplant Proc; 2015 Mar; 47(2):348-53. PubMed ID: 25769571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. World kidney day 2010: medical aspects of 10 live-donor renal transplantations in a single center from a developing country.
    Shah PR; Modi PR; Kute VB; Vanikar AV; Patel HV; Gumber MR; Shah VR; Trivedi HL
    Transplant Proc; 2012 Jan; 44(1):47-8. PubMed ID: 22310575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus.
    Ferreira A; Felipe C; Cristelli M; Viana L; Basso G; Stopa S; Mansur J; Ivani M; Bessa A; Ruppel P; Aguiar W; Campos E; Gerbase-DeLima M; Proença H; Tedesco-Silva H; Medina-Pestana J
    Am J Nephrol; 2017; 45(6):497-508. PubMed ID: 28511172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome of renal transplantation in end-stage renal disease patients with positive pretransplantation hepatitis B surface antigen.
    Patel HV; Kute VB; Vanikar AV; Shah PR; Gumber MR; Jain SH; Engineer DP; Ghelani GH; Trivedi HL
    Transplant Proc; 2012 Jan; 44(1):72-4. PubMed ID: 22310582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.